MedTrace Logo

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

NCT01776658 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-05-25

No results posted yet for this study

Summary

The aim of this pilot study is to compare the analgesic effect of SYL1001 versus placebo in patients with ocular pain associated with Dry Eye Syndrome. General and local tolerability are also evaluated.

Conditions

  • Ocular Pain
  • Dry Eye Syndrome

Interventions

DRUG

SYL1001

Ocular topical administration of SYL1001 for 10 consecutive days

DRUG

Placebo

Ocular topical administration of placebo for 10 consecutive days

Sponsors & Collaborators

  • Sylentis, S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01776658 on ClinicalTrials.gov